Eric Shi

Non-Equity Principal

  • Email

    shihao@zlwd.com

  • Tel

    +86-10-85673688

  • Office

    Beijing

Shi Hao Lawyer provides clients with legal services including patentability analysis, high-quality patent drafting and portfolio planning, patent reexamination and invalidation, patent administrative litigation and civil infringement litigation, patent ownership disputes, FTO analysis, trade secret infringement disputes, and trade secret information retrieval. He also handles trademark registration, trademark administrative disputes and trademark infringement disputes, and provides cross-border IP strategy and IP enforcement assistance for enterprises going global.

Mr. Shi has 13 years of working experience at the China National Intellectual Property Administration (CNIPA), having successively served in the positions of substantive examination, PCT examination, reexamination and preliminary examination. He was selected into the CNIPA Core Talent Pool and awarded the title of Examination Business Guidance Expert.

His practice covers new materials, new energy, biomedicine, general health, chemical engineering, medical devices, pesticides, optoelectronic technology, semiconductors and other fields.

Working Experience


  • 2025-2026 Kingland Partners   Partner
  • 2021-2024 SAELINK LAW   lawyer/ patent attorney
  • 2018-2021 Guozhi (Beijing) Certification Co., Ltd.   Senior Director
  • 2008-2018 China National Intellectual Property Administration, PRC   Patent Examiner


Achievements:


  • Represented LUMILEDS in a series of patent invalidation and infringement litigation cases (involving LED automotive lamps).
  • Represented a domestic listed company in a series of patent invalidation and patent administrative enforcement cases (involving high-speed rail sensors).
  • Represented WKV Dr. Grochowski Anlagentechnik GmbH in patent invalidation and non-litigation legal matters (involving industrial waste gases purification).
  • Representation in pharmaceutical patent invalidation cases (involving anti-brain ischemia drugs).
  • Provided freedom-to-operate (FTO) investigations in drug R&D for a well-known domestic pharmaceutical enterprise (involving chemical structures of pharmaceutical compounds).
  • Represented CATL as patent owner in handling invention patent invalidation cases (involving power batteries).
  • Provided patent prosecution services for medical device companies including ResMed and Edwards Lifesciences, achieving expected objectives.
  • Handled patent application and patent reexamination matters for pharmaceutical companies including Wyeth and Biogen, achieving expected objectives.
  • Represented for Hangzhou Guangmao Outdoor Products, handling registration and application matters relating to trademarks and design patents in the EU and UK.
  • Represented Hangzhou Gaoqi in handling legal matters relating to designs and trademarks in the EU, Australia and Morocco.
  • Assisted a biopharmaceutical company in resolving patent application ownership disputes (involving ADC drugs).


expand

Honors


  • Associate Research Fellow
  • High-level Talent at the China National Intellectual Property Administration (CNIPA)
  • Expert in the Intellectual Property Expert Database of Beijing, Fujian, Hainan and Shanxi.


expand

Education

Beijing University of Chemical Technology, Materials Science

Professional Qualifications

PRC Lawyer’s Practicing Qualification
China Patent Bar

Languages

Chinese and English